| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700848 | European Journal of Surgical Oncology (EJSO) | 2017 | 7 Pages |
Abstract
The courses of IIPMN and PDAC were similar after an optimized stage-to-stage comparison. Adjuvant chemotherapy was efficient in both groups. However, in lymph node negative patients, adjuvant chemotherapy seemed not to have a significant impact.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
P. Duconseil, J. Périnel, A. Autret, M. Adham, A. Sauvanet, L. Chiche, J.-Y. Mabrut, J.-J. Tuech, C. Mariette, N. Régenet, J.-M. Fabre, P. Bachellier, J.-R. Delpéro, F. Paye, O. Turrini,